Skip to main content
. 2019 Oct 30;43(1):188–200. doi: 10.3892/or.2019.7394

Figure 1.

Figure 1.

Expression levels of RLIP76 in patients with IDH1Wt and IDH1Mut GBM. (A) LinkedOmics analysis of The Cancer Genome Atlas database revealed that RLIP76 is overexpressed in IDH1Wt GBM tissues compared with IDH1Mut GBM tissues. P=0.0406. (B) Representative images of immunohistochemical staining for RLIP76 in IDH1Wt and IDH1Mut GBM tissues. (C) mRNA expression levels of RLIP76 measured in IDH1Wt and IDH1Mut GBM tissues by reverse transcription-quantitative PCR. *P<0.05. (D) Protein expression levels of RLIP76 measured in IDH1Wt and IDH1Mut GBM tissues by western blot analysis. RLIP76, ralA binding protein 1; IDH1, IDH1, isocitrate dehydrogenase 1; Wt, wild-type; Mut, mutant; GBM, glioblastoma multiforme.